Finn Patrick John: insider trades.
Finn Patrick John reported 11 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 10 sales ($10.2M), across 1 company.
- Transactions
- 11
- Purchases (P)
- 0
- Sales (S)
- 10
- Companies
- 1
- Name as filed
- Finn Patrick John
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Twist Bioscience Corp (TWST) | Officer · President and COO | 11 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-21 | Twist Bioscience Corp | S | 4,046 | $139.07 | 210,802 | Form 4 |
| 2026-08-18 | Twist Bioscience Corp | S | 2,000 | $122.58 | 214,678 | Form 4 |
| 2026-08-18 | Twist Bioscience Corp | S | 6,296 | $121.01 | 216,678 | Form 4 |
| 2026-08-18 | Twist Bioscience Corp | S | 12,917 | $119.86 | 222,974 | Form 4 |
| 2026-08-18 | Twist Bioscience Corp | S | 4,500 | $119.04 | 235,891 | Form 4 |
| 2026-08-18 | Twist Bioscience Corp | S | 8,868 | $117.7 | 240,391 | Form 4 |
| 2026-08-18 | Twist Bioscience Corp | S | 10,420 | $116.82 | 249,259 | Form 4 |
| 2026-08-18 | Twist Bioscience Corp | M | 23,355 | $67.85 | 293,033 | Form 4 |
| 2026-08-18 | Twist Bioscience Corp | S | 33,354 | $115.9 | 259,679 | Form 4 |
| 2026-08-03 | Twist Bioscience Corp | S | 2,888 | $85.32 | 269,678 | Form 4 |
| 2026-07-23 | Twist Bioscience Corp | S | 2,238 | $93.89 | 272,566 | Form 4 |
Questions
What stock did Finn Patrick John buy or sell?
Finn Patrick John reported 11 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 10 sales ($10.2M), across 1 company.
Is Finn Patrick John the same person as other filers with this name?
This page covers SEC CIK 1755970 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/finn-patrick-john-1755970.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.